Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. (IXHL) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $40.3M; returns 1 day +1.5%, 1 week -6.4%, 1 year -74.2%.

Incannex Healthcare Ltd ADR (IXHL) is a clinical-stage biopharmaceutical company based in Australia, focused on developing novel therapies and psychedelic medicines for treating chronic diseases. The company's approach involves combining synthetic cannabinoids with well-characterized active drug components to create innovative oral fixed-dose treatments.

Groups IXHL belongs to

• Healthcare
• Recent Reverse Splits
• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage
• Cannabis
• Mental Health Solutions
• Sleep Apnea
• Pharmaceuticals
• Chronic Disease Management

IXHL financial model: income statement, cash flow and balance sheet